[Federal Register: May 21, 2009 (Volume 74, Number 97)]
[Notices]
[Page 23867-23868]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21my09-59]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): A Creutzfeldt-Jakob Disease (CJD) Lookback Study:
Assessing the Risk of Blood Borne Transmission of Classic Forms of
Creutzfeldt-Jakob Disease, Funding Opportunity Announcement (FOA) CK09-
002, Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Date: 12 p.m.-3 p.m., June 5, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the initial
review, discussion, and evaluation of `` A Creutzfeldt-Jakob Disease
Lookback Study: Assessing the Risk of Blood Borne Transmission of
Classic Forms of Creutzfeldt-Jakob Disease, FOA CK09-002.''
Contact Person for More Information: Wendy Carr, Ph.D., CDC,
1600 Clifton Road, NE., Mailstop D60, Atlanta, GA 30333, Telephone:
(404) 498-2276.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices
[[Page 23868]]
pertaining to announcements of meetings and other committee
management activities, for both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 15, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-11905 Filed 5-20-09; 8:45 am]
BILLING CODE 4163-18-P